Molecular mechanisms and treatment strategies for Dupuytren’s disease

References

• PrattALByrneGThe lived experience of Dupuytren’s disease of the handJ Clin Nurs200918121793180219220604
   PubMed Web of Science ®Google Scholar
• RayanGMDupuytren disease: Anatomy, pathology, presentation, and treatmentJ Bone Joint Surg Am200789118919817256226
   PubMedGoogle Scholar
• ShawRBJrChongAKZhangAHentzVRChangJDupuytren’s disease: history, diagnosis, and treatmentPlast Reconstr Surg2007120344e54e
   PubMed Web of Science ®Google Scholar
• McFarlaneRMPatterns of the diseased fascia in the fingers in Dupuytren’s contracture. Displacement of the neurovascular bundlePlast Reconstr Surg197454131444832466
   PubMed Web of Science ®Google Scholar
• WatsonHKPaulHJrPathologic anatomyHand Clin1991746616681769988
   PubMedGoogle Scholar
• RossDCEpidemiology of Dupuytren’s diseaseHand Clin19991515362vi10050242
   PubMed Web of Science ®Google Scholar
• ChildsSGDupuytren’s diseaseOrthop Nurs2005242160163 quiz 164–16515902016
   PubMed Web of Science ®Google Scholar
• McFarlaneRMOn the origin and spread of Dupuytren’s diseaseJ Hand Surg Am200227338539012015711
   PubMed Web of Science ®Google Scholar
• EgawaTSenruiHHorikiAEgawaMEpidemiologoy of the Oriental patientDupuytren’s disease Biology and TreatmentEdinburgh, UKChurchill Livingstone1990239245
   Google Scholar
• GudmundssonKGArngrimssonRSigfussonNBjornssonAJonssonTEpidemiology of Dupuytren’s disease: clinical, serological, and social assessment. The Reykjavik StudyJ Clin Epidemiol200053329129610760640
   PubMed Web of Science ®Google Scholar
• HuestonJThe Dupuytren’s diathesisDupuytren’s ContractureEdinburgh, UKChurchill Livingstone19635163
   Google Scholar
• HindochaSStanleyJKWatsonSBayatADupuytren’s diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrenceJ Hand Surg [Am]2006311016261634
   PubMedGoogle Scholar
• CaglieroEApruzzeseWPerlmutterGSNathanDMMusculoskeletal disorders of the hand and shoulder in patients with diabetes mellitusAm J Med2002112648749011959060
   PubMed Web of Science ®Google Scholar
• ArkkilaPEKoskinenPJKantolaIMRonnemaaTSeppanenEViikariJSDupuytren’s disease in type I diabetic subjects: investigation of biochemical markers of type III and I collagenClin Exp Rheumatol200018221521910812494
   PubMed Web of Science ®Google Scholar
• ArafaMNobleJRoyleSGTrailIAAllenJDupuytren’s and epilepsy revisitedJ Hand Surg Br19921722212241588209
   PubMedGoogle Scholar
• BurgePHoyGReganPMilneRSmoking, alcohol and the risk of Dupuytren’s contractureJ Bone Joint Surg Br19977922062109119843
   PubMedGoogle Scholar
• GodtfredsenNSLuchtHPrescottESorensenTIGronbaekMA prospective study linked both alcohol and tobacco to Dupuytren’s diseaseJ Clin Epidemiol200457885886315485739
   PubMed Web of Science ®Google Scholar
• GudmundssonKGArngrimssonRJonssonTDupuytren’s disease, alcohol consumption and alcoholismScand J Prim Health Care200119318619011697563
   PubMed Web of Science ®Google Scholar
• LucasGBrichetARoquelaureYLeclercADescathaADupuytren’s disease: personal factors and occupational exposureAm J Ind Med200851191518033693
   PubMed Web of Science ®Google Scholar
• LoganAJMasonGDiasJMakwanaNCan rock climbing lead to Dupuytren’s disease?Br J Sports Med200539963964416118302
   PubMed Web of Science ®Google Scholar
• ThomasPRClarkeDVibration white finger and Dupuytren’s contracture: are they related?Occup Med (Lond)19924231551581345125
   PubMed Web of Science ®Google Scholar
• LoosBPuschkinVHorchRE50 years experience with Dupuytren’s contracture in the Erlangen University Hospital – a retrospective analysis of 2919 operated hands from 1956 to 2006BMC Musculoskelet Disord200786017610744
   PubMed Web of Science ®Google Scholar
• ElliotDThe early history of Dupuytren’s diseaseHand Clin1999151119v10050238
   PubMed Web of Science ®Google Scholar
• RayanGMNonoperative treatment of Dupuytren’s diseaseJ Hand Surg Am20083371208121018762122
   PubMedGoogle Scholar
• HuestonJTThe table top testHand19821411001037060997
   PubMedGoogle Scholar
• RossDCGanBSAcquired diseases of the handSiemionowMTextbook of Plastic SurgeryNew York, NYSpringer2010583597
   Google Scholar
• SwartzWMLalondeDHMOC-PS(SM) CME article: Dupuytren’s diseasePlast Reconstr Surg2008121Suppl 411018379378
   PubMedGoogle Scholar
• McIndoeABeareRLThe surgical management of Dupuytren’s contractureAm J Surg195895219720313487940
   PubMed Web of Science ®Google Scholar
• RowleyDICouchMChesneyRBNorrisSHAssessment of percutaneous fasciotomy in the management of Dupuytren’s contractureJ Hand Surg Br1984921631646747419
   PubMedGoogle Scholar
• van RijssenALWerkerPMPercutaneous needle fasciotomy in dupuytren’s diseaseJ Hand Surg Br200631549850116766101
   PubMedGoogle Scholar
• ChengHSHungLKTseWLHoPCNeedle aponeurotomy for Dupuytren’s contractureJ Orthop Surg (Hong Kong)2008161889018453667
   PubMedGoogle Scholar
• FoucherGMedinaJNavarroRPercutaneous needle aponeurotomy: complications and resultsJ Hand Surg2003285427431
   PubMedGoogle Scholar
• BrotherstonTMBalakrishnanCMilnerRHBrownHGLong term follow-up of dermofasciectomy for Dupuytren’s contractureBr J Plast Surg19944764404437952813
   PubMedGoogle Scholar
• ArmstrongJRHurrenJSLoganAMDermofasciectomy in the management of Dupuytren’s diseaseJ Bone Joint Surg Br2000821909410697321
   PubMedGoogle Scholar
• LarsonDJerosch-HeroldCClinical effectiveness of post-operative splinting after surgical release of Dupuytren’s contracture: a systematic reviewBMC Musculoskelet Disord2008910418644117
   PubMed Web of Science ®Google Scholar
• EvansRBDellPCFiolkowskiPA clinical report of the effect of mechanical stress on functional results after fasciectomy for Dupuytren’s contractureJ Hand Ther200215433133912449347
   PubMedGoogle Scholar
• McFarlaneRMMcGroutherDAComplications and their managementMcFarlaneRMFlintDADupuytren’s DiseaseEdinburgh, UKChurchill Livingstone1990348364
   Google Scholar
• HuestonJTEnzymic fasciotomyHand19713138405098337
   PubMedGoogle Scholar
• BaileyAJSimsTJGabbianiGBazinSLeLousMCollagen of Dupuytren’s diseaseClin Sci Mol Med1977535499502589933
   PubMedGoogle Scholar
• Brickley-ParsonsDGlimcherMJSmithRJAlbinRAdamsJPBiochemical changes in the collagen of the palmar fascia in patients with Dupuytren’s diseaseJ Bone Joint Surg Am19816357877977240301
   PubMed Web of Science ®Google Scholar
• HurstLCBadalamenteMAHentzVRInjectable collagenase clostridium histolyticum for Dupuytren’s contractureN Engl J Med20093611096897919726771
   PubMed Web of Science ®Google Scholar
• BadalamenteMAHurstLCHentzVRCollagen as a clinical target: nonoperative treatment of Dupuytren’s diseaseJ Hand Surg Am200227578879812239666
   PubMedGoogle Scholar
• BadalamenteMAHurstLCEfficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren’s contractureJ Hand Surg Am200732676777417606053
   PubMed Web of Science ®Google Scholar
• WattAJCurtinCMHentzVRCollagenase injection as nonsurgical treatment of dupuytren’s disease: 8-year follow-upJ Hand Surg Am2010354534539539 e53120353858
   PubMedGoogle Scholar
• KetchumLDDonahueTKThe injection of nodules of Dupuytren’s disease with triamcinolone acetonideJ Hand Surg Am20002561157116211119679
   PubMedGoogle Scholar
• PagnottaASpecchiaNSoccettiAManzottiSGrecoFResponsiveness of Dupuytren’s disease fibroblasts to 5 alpha-dihydrotestosteroneJ Hand Surg Am20032861029103414642522
   PubMedGoogle Scholar
• MeekRMMcLellanSReillyJCrossanJFThe effect of steroids on Dupuytren’s disease: role of programmed cell deathJ Hand Surg Br200227327027312074617
   PubMedGoogle Scholar
• NewmanRJLocal skin depigmentation due to corticosteroid injectionBr Med J (Clin Res Ed)1984288643217251726
   PubMedGoogle Scholar
• OikarinenAAutioPNew aspects of the mechanism of corticosteroid-induced dermal atrophyClin Exp Dermatol19911664164191806315
   PubMed Web of Science ®Google Scholar
• PittetBRubbia-BrandtLDesmouliereAEffect of gamma-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren’s disease: an open pilot studyPlast Reconstr Surg1994936122412358171142
   PubMed Web of Science ®Google Scholar
• SandersJLDoddCGhaharyAScottPGTredgetEEThe effect of interferon-alpha2b on an in vitro model Dupuytren’s contractureJ Hand Surg Am199924357858510357539
   PubMed Web of Science ®Google Scholar
• TanakaKSanoKNakanoTYubaKKinoshitaMSuppression of alpha smooth muscle actin expression by IFN-gamma in established myofibroblast cell linesJ Interferon Cytokine Res2007271083583917970692
   PubMed Web of Science ®Google Scholar
• BowleyEO’GormanDBGanBSBeta-catenin signaling in fibroproliferative diseaseJ Surg Res2007138114115017109886
   PubMed Web of Science ®Google Scholar
• JohnstonPLarsonDClarkIMChojnowskiAJMetalloproteinase gene expression correlates with clinical outcome in Dupuytren’s diseaseJ Hand Surg Am20083371160116718762113
   PubMedGoogle Scholar
• UlrichDHrynyschynKPalluaNMatrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren’s diseasePlast Reconstr Surg200311251279128614504511
   PubMed Web of Science ®Google Scholar
• HutchinsonJWTierneyGMParsonsSLDavisTRDupuytren’s disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitorJ Bone Joint Surg Br19988059079089768907
   PubMedGoogle Scholar
• TownleyWACambreyADKhawPTGrobbelaarAOThe role of an MMP inhibitor in the regulation of mechanical tension by Dupuytren’s disease fibroblastsJ Hand Surg Eur Vol200934678378719786408
   PubMedGoogle Scholar
• TownleyWACambreyADKhawPTGrobbelaarAOMatrix metalloproteinase inhibition reduces contraction by dupuytren fibroblastsJ Hand Surg Am20083391608161618984345
   PubMedGoogle Scholar
• PasternakBAspenbergPMetalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedicsActa Orthop200980669370319968600
   PubMed Web of Science ®Google Scholar
• QianAMealsRARajferJGonzalez-CadavidNFComparison of gene expression profiles between Peyronie’s disease and Dupuytren’s contractureUrology200464239940415302515
   PubMed Web of Science ®Google Scholar
• RehmanSSalwayFStanleyJKOllierWEDayPBayatAMolecular phenotypic descriptors of Dupuytren’s disease defined using informatics analysis of the transcriptomeJ Hand Surg Am200833335937218343292
   PubMedGoogle Scholar
• ShihBBrownJJArmstrongDJLindauTBayatADifferential Gene expression analysis of subcutaneous fat, fascia, and Skin overlying a Dupuytren’s disease Nodule in comparison to control tissueHand (NY)200943294301
   PubMedGoogle Scholar
• SatishLLaframboiseWAO’GormanDBIdentification of differentially expressed genes in fibroblasts derived from patients with Dupuytren’s ContractureBMC Med Genomics200811018433489
   PubMed Web of Science ®Google Scholar
• ViLFengLZhuRDPeriostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren’s disease and adjacent palmar fascia cellsExp Cell Res2009315203574358619619531
   PubMed Web of Science ®Google Scholar
• HowardJCVaralloVMRossDCElevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren’s disease cells are regulated by tension in vitroBMC Musculoskelet Disord200341612866952
   PubMed Web of Science ®Google Scholar
• HowardJCVaralloVMRossDCWound healing-associated proteins Hsp47 and fibronectin are elevated in Dupuytren’s contractureJ Surg Res2004117223223815047128
   PubMed Web of Science ®Google Scholar
• ShihBWijeratneDArmstrongDJLindauTDayPBayatAIdentification of biomarkers in Dupuytren’s disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypesJ Hand Surg Am200934112413619121738
   PubMedGoogle Scholar
• SedicMJurisicDStanecZHockKPavelicKKraljevic PavelicSFunctional genomics in identification of drug targets in Dupuytren’s contractureFront Biosci201015576420036806
   PubMed Web of Science ®Google Scholar
• Kraljevic PavelicSSedicMHockKAn integrated proteomics approach for studying the molecular pathogenesis of Dupuytren’s diseaseJ Pathol2009217452453319089850
   PubMed Web of Science ®Google Scholar
• VaralloVMGanBSSeneySBeta-catenin expression in Dupuytren’s disease: potential role for cell-matrix interactions in modulating beta-catenin levels in vivo and in vitroOncogene200322243680368412802275
   PubMed Web of Science ®Google Scholar
• ViLGanBSO’GormanDBThe potential roles of cell migration and extra-cellular matrix interactions in Dupuytren’s disease progression and recurrenceMed Hypotheses201074351051219896280
   PubMed Web of Science ®Google Scholar
• ViLNjarlangattilAWuYGanBSO’GormanDBType-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren’s Disease cord and adjacent palmar fascia cellsBMC Musculoskelet Disord2009107219545383
   PubMed Web of Science ®Google Scholar
• LoechelFFoxJWMurphyGAlbrechtsenRWewerUMADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3Biochem Biophys Res Commun2000278351151511095942
   PubMed Web of Science ®Google Scholar
• ShiZXuWLoechelFWewerUMMurphyLJADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3J Biol Chem200027524185741858010849447
   PubMed Web of Science ®Google Scholar
• DenysHJadidizadehAAmini NikSIdentification of IGFBP-6 as a significantly downregulated gene by beta-catenin in desmoid tumorsOncogene200423365466414737101
   PubMed Web of Science ®Google Scholar
• ChenXFerryRJJrNovel actions of IGFBP-3 on intracellular signaling pathways of insulin-secreting cellsGrowth Horm IGF Res2006161414816275148
   PubMed Web of Science ®Google Scholar
• CusiKDeFronzoRRecombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistanceJ Clin Endocrinol Metab20008593077308410999789
   PubMed Web of Science ®Google Scholar
• Lopez-BermejoAKhosraviJFernandez-RealJMInsulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25)Diabetes20065582333233916873698
   PubMed Web of Science ®Google Scholar
• Mohamed-AliVPinkneyJTherapeutic potential of insulin-like growth factor-1 in patients with diabetes mellitusTreat Endocrinol20021639941015832492
   PubMedGoogle Scholar
• HartMGHooperGClinical associations of Dupuytren’s diseasePostgrad Med J20058195742542815998816
   PubMed Web of Science ®Google Scholar
• ArkkilaPEKantolaIMViikariJSDupuytren’s disease: association with chronic diabetic complicationsJ Rheumatol19972411531599002027
   PubMed Web of Science ®Google Scholar
• CarrieriMPSerrainoDPalmiottoFNucciGSassoFA case-control study on risk factors for Peyronie’s diseaseJ Clin Epidemiol19985165115159636000
   PubMed Web of Science ®Google Scholar
• ClassenDAHurstLNPlantar fibromatosis and bilateral flexion contractures: a review of the literatureAnn Plast Surg19922854754781622023
   PubMed Web of Science ®Google Scholar
• DonatoRRMorrisonWADupuytren’s disease in the feet causing flexion contractures in the toesJ Hand Surg1996213364366
   Google Scholar
• SmithSPDevaraj vs BunkerTDThe association between frozen shoulder and Dupuytren’s diseaseJ Shoulder Elbow Surg200110214915111307078
   PubMed Web of Science ®Google Scholar
• BunkerTDAnthonyPPThe pathology of frozen shoulder. A Dupuytren-like diseaseJ Bone Joint Surg Br19957756776837559688
   PubMedGoogle Scholar
• BunkerTDReillyJBairdKSHamblenDLExpression of growth factors, cytokines and matrix metalloproteinases in frozen shoulderJ Bone Joint Surg Br200082576877310963182
   PubMedGoogle Scholar
• LeeYCChanHHBlackMMAggressive polyfibromatosis: a 10 year follow-upAustralas J Dermatol19963742052078961590
   PubMedGoogle Scholar